CoChat
Cited by 180

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Targeting Cancer Cells with BET Bromodomain Inhibitors

Open access
Xu, Yali, Vakoc, Christopher R. · 2017 · Cold Spring Harbor Perspectives in Medicine

Abstract

Cancer cells are often hypersensitive to the targeting of transcriptional regulators, which may reflect the deregulated gene expression programs that underlie malignant transformation. One of the most prominent transcriptional vulnerabilities in human cancer to emerge in recent years is the bromodomain and extraterminal (BET) family of proteins, which are coactivators that link acetylated transcription factors and histones to the activation of RNA polymerase II. Despite unclear mechanisms underlying the gene specificity of BET protein function, small molecules targeting these regulators preferentially suppress the transcription of cancer-promoting genes. As a consequence, BET inhibitors elicit anticancer activity in numerous malignant contexts at doses that can be tolerated by normal tissues, a finding supported by animal studies and by phase I clinical trials in human cancer patients. In this review, we will discuss the remarkable, and often perplexing, therapeutic effects of BET bromodomain inhibition in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/cshperspect.a026674

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Selective inhibition of BET bromodomains

    Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · cited 6×

    “…cell lines to JQ1 leads to a rapid eviction of BRD4–NUT from chromatin, followed by a rapid suppression of its direct target genes, such as MYC, and the induction of terminal squamous cell differentiation (Filippakopoulos et al. 2010; Yan et al. 2011; Grayson et al. 2014; Alekseyenko et al. 2015).”
    BackgroundMethodInfluential
  • Super-enhancers in the control of cell identity and disease

    Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662 · cited 2×

    “” Indeed, genes with a large number of enhancers tend to encode lineage-specific and growth-regulatory factors (Hnisz et al. 2013; Whyte et al. 2013).”
    Background
  • Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

    Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961 · cited 10×

    “Using genomic approaches applied to several different cell types, it has been observed that genes with “superenhancers” nearby tend to be more suppressed by JQ1 than randomly chosen expressed genes (Chapuy et al. 2013; Lovén et al. 2013; Peeters et al. 2015).”
    BackgroundMethodInfluentialSelf-citation
  • Combinatorial patterns of histone acetylations and methylations in the human genome

    Wang, Z., Zang, C., Rosenfeld, J. A., Schones, D. E., Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Peng, W., Zhang, M. Q., et al. (2008) · Nature Genetics · doi:10.1038/ng.154 · Cited by 2,331

  • RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

    Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870

    Self-citation
  • Phthalimide conjugation as a strategy for in vivo target protein degradation

    Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760 · cited 2×

    “A more recent innovation in BET inhibitor design has been to conjugate JQ1 with chemical moieties that promote recruitment of E3 ubiquitin ligases, which leads to polyubiquitylation of BET proteins and proteasome-dependent degradation, a strategy known as proteolysis targeting chimera (PROTAC) (Lu et al. 2015; Winter…”
    Background
  • Structure and ligand of a histone acetyltransferase bromodomain

    Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732 · cited 3×

    “…Press; all rights reserved; doi: 10.1101/cshperspect.a026674 Cite this article as Cold Spring Harb Perspect Med 2017;7:a026674 1 w w w .p er sp ec ti ve si n m ed ic in e. o rg which is present on 46 different proteins encoded in the human genome (Dhalluin et al. 1999; Filippakopoulos et al. 2012).”
    BackgroundInfluential
  • Suppression of inflammation by a synthetic histone mimic

    Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563 · cited 5×

    “Of note, both JQ1 and iBET are pan-BET bromodomain inhibitors, which do not discriminate between the two bromodomains within the same BET protein, nor among the four BET family members (Filippakopoulos et al. 2010; Nicodeme et al. 2010).”
    BackgroundMethodInfluential
  • Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

    Lu, J., Qian, Y., Altieri, M., Dong, H., Wang, J., Raina, K., Hines, J., Winkler, J. D., Crew, A. P., Coleman, K., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.05.009 · Cited by 1,140

  • Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4

    Zengerle, M., Chan, K.-H., & Ciulli, A. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00216 · Cited by 1,056 · cited 2×

    “A more recent innovation in BET inhibitor design has been to conjugate JQ1 with chemical moieties that promote recruitment of E3 ubiquitin ligases, which leads to polyubiquitylation of BET proteins and proteasome-dependent degradation, a strategy known as proteolysis targeting chimera (PROTAC) (Lu et al. 2015; Winter…”
    Background

Show all 22 references

Cited by

Metadata

Authors
Xu, Y., & Vakoc, C. R.
Venue
Cold Spring Harbor Perspectives in Medicine
Published
2017-02-17
Volume
7
Issue
7
Pages
a026674
ISSN
2157-1422 (ISSN-L)
OpenAlex
W2588654455
Cited by
180
References
22
Type
posted content
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.